pubrio
台康生技股份有限公司

台康生技股份有限公司

Taiwan · Research

Research

EirGenix is a contract development and manufacturing organization that provides high-quality and cost-effective service. We support our clients in the development, analytical testing, and cGMP manufacturing of biopharmaceuticals from pre-clinical to commercial manufacturing. EirGenix also specializes in the development of biologics, specializing in the development of biosimilars. Our Services: - Cell Line Development (mammalian/microbial systems) - Process Development and Process Optimization - Analytical Services and Quality Control - cGMP Manufacturing (mammalian/microbial systems) - Taiwan FDA inspected/approved - Japan PMDA inspected/approved - U.S. FDA inspection pending (June 2022) - EMA inspection pending (2022-2023) - Antibody-Drug Conjugate (ADC) Development and Manufacturing

Company Insights
Company Overview

2012

Founded

Research

Industry

Taiwan

Location

2,662,696

Ranking

300 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding 台康生技股份有限公司

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​